Healthcare Trust Of America, Inc. (NYSE:HTA) Valuation According To Analysts

The stock is now showing YTD performance of 5.36 Percent. Franklin Resources Inc stated it has 4.96M shares or 0.11% of all its holdings.

A number of other hedge funds also recently made changes to their positions in the company. Zacks Investment Research lowered shares of Healthcare Trust of America from a "hold" rating to a "sell" rating in a research report on Tuesday, December 27th. Mizuho has "Buy" rating and $32 target. Daiwa Securities Group Inc. now owns 10,382,397 shares of the real estate investment trust's stock valued at $322,997,000 after purchasing an additional 2,586,706 shares during the period. Additionally Healthcare Trust of America, In declared a dividend for shareholders payable on Friday October 6th, 2017.

Coliseum Capital Management Llc holds 60.83% of its portfolio in The Providence Service Corporation for 1.97 million shares. Public Employees Retirement Association of Colorado increased its stake in Healthcare Trust of America by 44.0% during the second quarter. Baird Financial Group, Inc. now controls 296,281 shares valued at $9,217,000. Finally, Comerica Bank bought a new stake in Healthcare Trust of America during the first quarter worth approximately $202,000. The company was maintained on Tuesday, July 4 by Stifel Nicolaus. Institutional investors and hedge funds own 97.75% of the company's stock. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of worldwide copyright legislation.

07/11/2017 - Healthcare Trust of America, Inc. had its "mkt perform" rating reiterated by analysts at FBR Capital Markets.

Healthcare Trust of America, Inc.is a real estate investment trust. With the last stock price close up 0.20% from the two hundred day average, compared with the S&P 500 Index which has increased 0.04% over the date range. The stock had a trading volume of 1,101,529 shares. The company has market cap of $6.15 billion. The firm's 50 day moving average price is $29.86 and its 200-day moving average price is $30.56. As per Thursday, December 31, the company rating was maintained by Stifel Nicolaus.

Jimmy Kimmel doubles down on dumb health care arguments
On Thursday morning, an "emotional" Kilmeade responded to the comedian - both on Fox & Friends and on The Brian Kilmeade Show. The president also took a shot at GOP Sen. "Does that mean he'll vote against the disgusting bill he wrote? ".

Healthcare Trust of America, Inc. on 6/29/2017 reported its EPS as $0.04 with the analysts projecting the EPS of the stock as $0.09. The real estate investment trust reported $0.39 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.39. Healthcare Trust of America had a return on equity of 1.42% and a net margin of 6.07%. They expect $0.35 earnings per share, 0.00% or $0.00 from last year's $0.35 per share.

Analysts are also projecting an Average Revenue Estimate for Healthcare Trust of America, Inc.as $155810 in the Current Quarter.

On a similar note, analysts expect EPS of $0.41 in September 2017 quarter and $0.42 in December 2017 quarter, representing 2.5% and 0% growth, respectively. Healthcare Trust of America's dividend payout ratio is presently 571.43%. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. UBS AG raised Healthcare Trust of America from an "outperform" rating to a "strong-buy" rating in a research note on Monday, July 17th.

01/04/2016 - Oppenheimer began new coverage on Healthcare Trust of America, Inc. giving the company a "outperform" rating. Raymond James upgraded the stock to "Strong Buy" rating in Monday, July 17 report. Jefferies Group LLC raised Healthcare Trust of America to a "buy" rating and set a $36.00 price target on the stock in a report on Monday, June 5th. The company now has an average rating of "Buy" and a consensus target price of $34.14. The stock's last price was lower from the average trading price of 50 days recorded at $39.85 while enlarging the period to 200 trading days, the average price was $50.87. Following the completion of the transaction, the chief executive officer now directly owns 405,092 shares in the company, valued at $12,987,249.52. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The portion of a company's profit allocated to each outstanding share of common stock was $3.45 a share in the trailing twelve months. The Massachusetts-based Eagle Boston Investment Management Inc has invested 1.18% in the stock. The Company is an owner and operator of medical office buildings (MOBs) in the United States.

Latest News